SearchDictionaryMobileLogin

Ulrich Specks Selected Research

Wegener Granulomatosis (Wegener's Granulomatosis)

10/2008Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
05/2008Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.
12/2007The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event.
11/2007Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.
07/2007ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
05/2007Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations.
05/2006Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
01/2006Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
08/2005Methotrexate for Wegener's granulomatosis: what is the evidence?
07/2005Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
02/2004Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
12/2003Epidemiology of Wegener granulomatosis since the introduction of ANCA testing in Olmsted County, MN, 1990-1999.

Articles by Research Topic

Disease

12Wegener Granulomatosis (Wegener's Granulomatosis)
10/2008 - 12/2003
4Vasculitis (Vasculitides)
11/2007 - 09/2004
1Membranous Glomerulonephritis (Membranous Nephropathy)
08/2008
1Thrombophilia
12/2007
1Lung Neoplasms (Lung Cancer)
05/2006
1Melanoma (Melanoma, Malignant)
05/2006
1Sarcoidosis (Schaumann Disease)
08/2004
1Churg-Strauss Syndrome (Allergic Angiitis)
09/2003
1Pulmonary Sarcoidosis
07/2003
1Necrosis
01/2003

Drug/Important Bio-Agent (IBA)

8Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2007 - 09/2003
3rituximab (Mabthera)FDA Link
10/2008 - 01/2006
3TNFR-Fc fusion protein (etanercept)FDA Link
05/2006 - 07/2003
2Cocaine (Cocaine HCl)IBA
09/2004 - 01/2003
1GlucocorticoidsIBA
05/2008
1Anticardiolipin AntibodiesIBA
12/2007
1AntibodiesIBA
05/2007
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
04/2007
1AntigensIBA
05/2006
1Methotrexate (Mexate)FDA LinkGeneric
08/2005
1Leukocyte Elastase (Neutrophil Elastase)IBA
09/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2004
1Myeloblastin (Proteinase 3)IBA
02/2004
1Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
09/2003

Therapy/Procedure

1Remission Induction
01/2005